Related Experiment Videos
Genetically modified immunocompetent cells in HIV infection
1Department of Histology, Microbiology and Medical Biotechnologies, University of Padua, Italy.
Gene Therapy
|March 16, 2002
Summary
Gene therapy offers a promising approach for HIV infection, complementing HAART. Genetically modified immune cells can restore immune function, aiding in controlling HIV progression and AIDS pathogenesis.
Area of Science:
- Immunology
- Gene Therapy
- Virology
Background:
- Highly active antiretroviral therapy (HAART) has advanced HIV management.
- Gene therapy (GT) presents a potential complementary strategy for HIV suppression.
- Existing treatments may not fully restore immune function against HIV and opportunistic infections.
Purpose of the Study:
- To discuss the potential of genetically modified immunocompetent cells for HIV immunotherapy.
- To explore cellular therapies involving gene-modified CD8 and CD4 lymphocytes.
- To evaluate the reconstitution of antigen-specific immune repertoires in HIV-infected individuals.
Main Methods:
- Review of existing research on gene therapy vectors and targets for HIV.
- Discussion of adoptive autologous immunotherapy using genetically modified cells.
- Focus on reconstituting antigen-specific cellular immunity.
Main Results:
- Gene therapy, particularly with modified lymphocytes, shows potential for HIV control.
- Reconstitution of immune responses specific to HIV and opportunistic pathogens is achievable.
- While complete eradication may be difficult, immune reconstitution can manage disease progression.
Conclusions:
- Genetically modified cellular therapies are a promising avenue for HIV management.
- Restoring antigen-specific immunity is crucial for controlling HIV infection and AIDS.
- Gene therapy can enhance immune competence, offering a valuable addition to HAART.